Pancreatic Adenocarcinoma Metastatic trials recruiting in Ohio

Fewer than 3 recruiting trials found.

All Pancreatic Adenocarcinoma Metastatic trials nationally

Cities in Ohio

Recruiting trials in Ohio

• Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
  NCT07562152 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Maumee
• Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
  NCT07491445 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cincinnati, Maumee